We are live on
!
Find out more
ONC
BeOne Medicines Ltd
219 hedge funds and large institutions have $10.3B invested in BeOne Medicines Ltd in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 71 increasing their positions, 64 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
111% more call options, than puts
Call options by funds: $37.3M | Put options by funds: $17.7M
23% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 30
11% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 64
3% more funds holding
Funds holding: 213 → 219 (+6)
0.14% less ownership
Funds ownership: 3.66% → 3.52% (-0.14%)
5% less capital invested
Capital invested by funds: $10.9B → $10.3B (-$581M)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Holders
219
Holders Change
+6
Holders Change %
+2.82%
% of All Funds
3.49%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.18%
New
37
Increased
71
Reduced
64
Closed
30
Calls
$37.3M
Puts
$17.7M
Net Calls
+$19.6M
Net Calls Change
+$9.79M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$75.5M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$44.1M |
| 3 |
AI
Axiom Investors
Greenwich,
Connecticut
|
+$39.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$24M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$20.8M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$323M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$50.8M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$48.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$39.2M |
| 5 |
Temasek Holdings
Singapore
|
-$34.4M |
